More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...

An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.

Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...

Pierre Fabre Pharmaceuticals Inc., today announced updated results presented at the 67th American Society of Hematology (ASH) ...

Throughout the 2000s, the music charts were rife with references to Rogaine. Jay-Z invoked the hair-restoration drug as a ...

Taking daily supplements has always been an important part of a healthy lifestyle. However, some once-popular Baby Boomer supplements turned out to be toxic. These supplements in particular have ...

Lawmakers passed a number of bills to "Make Texas Healthy Again." They also made it easier for Texans to avoid vaccines.

A few months after SK Life Science began rolling out a road trip-themed TV commercial for its antiseizure medication Xcopri, the FDA is attempting to put the brakes on the ad. The regulator late last ...

Microsoft is testing a new ad label for the Bing Search ads labeled "Ads related to" followed by the query the ads are related to. In the example below, it shows "Ad related to: Cushions" Sachin wrote ...

The FDA’s Office of Prescription Drug Promotion issued an Untitled Letter, backdated to September 23, to Tracey M. Henderson, MS, MBA – AstraZeneca’s promotional regulatory affairs review director, ...

Studies in the early 2000s claimed there were major risks associated with HRT. The Food and Drug Administration said Monday it will remove the "black box" warning from hormone replacement therapy (HRT ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...